stockrow
Friday 6 November 2026
Export HCSG’s income statement to Excel — free account
Healthcare Services Group, Inc.
HCSG Healthcare Medical Care Facilities
Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.29%
- EPS
- −37.3%
- Free cash flow
- −59.8%
Quarter to September 2026, against a year earlier
25.13
1.41
−5.31%
Follow HCSG
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.54 | 14.20 | 19.32 | 23.32 |
+8 more quarters Free account |
P/S ratio |
0.74 | 0.91 | 0.70 | 0.75 | |
P/FCF ratio |
13.01 | 11.36 | 8.31 | 9.94 | |
P/Operating CF |
46.10 | 77.22 | 29.63 | 79.59 | |
P/B ratio |
2.62 | 3.25 | 2.52 | 2.71 | |
Price to Tangible BV |
3.28 | 4.02 | 3.03 | 3.27 | |
EV/Sales |
0.64 | 0.81 | 0.60 | 0.66 | |
EV/EBITDA |
9.39 | 10.57 | 14.50 | 18.37 | |
EV/Operating CF |
10.71 | 9.81 | 6.86 | 8.31 | |
EV/FCF |
11.34 | 10.17 | 7.10 | 8.65 | |
Quick Ratio |
2.61 | 2.79 | 2.88 | 3.16 | |
Current Ratio |
2.82 | 3.02 | 3.11 | 3.38 | |
Net Debt/EBITDA |
(5.69) | (7.80) | (5.69) | (6.87) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
2.27 | 2.30 | 2.26 | 2.30 | |
Operating CF/Net income |
1.21 | 0.96 | 1.68 | 0.56 | |
Capex/Depreciation |
(0.52) | (0.44) | (0.35) | (0.36) | |
Interest Coverage |
100.43 | 35.88 | 92.70 | 69.18 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.10% | 11.17% | 9.08% | 9.90% | |
Intangible Assets out of Total Assets |
0.13 | 0.12 | 0.11 | 0.11 | |
Share Based Compensation of Revenue |
0.61% | 0.60% | 0.60% | 0.67% | |
Graham Net Nets |
0.19 | 0.16 | 0.23 | 0.21 | |
Graham Number |
16.29 | 17.14 | 12.60 | 11.40 | |
Earnings Yield |
7.38% | 7.04% | 5.18% | 4.29% | |
Free Cash Flow Yield |
7.68% | 8.81% | 12.03% | 10.06% | |
Revenue per Share |
7.05 | 6.85 | 6.62 | 6.45 | |
Operating CF per Share |
0.44 | 0.32 | 0.63 | 0.24 | |
Capex per Share |
(0.03) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.41 | 0.30 | 0.61 | 0.22 | |
Cash per Share |
3.00 | 2.92 | 3.07 | 2.82 | |
Shareholders Equity per Share |
7.81 | 7.55 | 7.35 | 7.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.81 | 7.55 | 7.35 | 7.05 | |
Free Cash Flow |
28.12 | 20.33 | 42.39 | 16.03 | |
Working Capital |
376.34 | 380.41 | 407.86 | 406.04 | |
Capital Expenditures |
(2.05) | (1.54) | (1.34) | (1.36) | |
Net Current Asset Value |
263.81 | 266.51 | 300.15 | 292.37 | |
EV/EBIT |
10.64 | 11.84 | 18.63 | 24.83 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
12.21 | 13.22 | 21.83 | 28.51 | |
| Other line items | |||||
Average Receivables |
331.79 | 323.99 | 364.88 | 358.56 | |
Average Payables |
86.94 | 82.00 | 80.95 | 79.26 | |
Average Inventory |
16.37 | 16.60 | 16.58 | 16.77 | |
Average Assets |
827.35 | 811.53 | 818.90 | 798.51 | |
Average Common Equity |
513.73 | 497.94 | 513.98 | 505.07 |
Columns are period end dates · fundamentals updated 2 Nov 2026